Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma

DSpace/Manakin Repository

Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma

Citable link to this page

. . . . . .

Title: Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma
Author: Christensen, Brock C.; Marsit, Carmen J.; Lopez-Fagundo, Cristina Y.; Longacker, Jennifer L.; Nelson, Heather H.; Kelsey, Karl T.; Godleski, John Joseph; Houseman, Eugene Andres; Bueno, Raphael; Sugarbaker, David John

Note: Order does not necessarily reflect citation order of authors.

Citation: Christensen, Brock C., John J. Godleski, Carmen J. Marsit, E. A. Houseman, Cristina Y. Lopez-Fagundo, Jennifer L. Longacker, Raphael Bueno, David J. Sugarbaker, Heather H. Nelson, and Karl T. Kelsey. 2008. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis 29(8): 1555-1559.
Full Text & Related Files:
Abstract: Malignant pleural mesothelioma (MPM) is a rapidly fatal tumor with increasing incidence worldwide responsible for many thousands of deaths annually. Although there is a clear link between exposure to asbestos and mesothelioma, and asbestos is known to be both clastogenic and cytotoxic to mesothelial cells, the mechanisms of causation of MPM remain largely unknown. However, there is a rapidly emerging literature that describes inactivation of a diverse array of tumor suppressor genes (TSGs) via promoter DNA CpG methylation in MPM, although the etiology of these alterations remains unclear. We studied the relationships among promoter methylation silencing, asbestos exposure, patient demographics and tumor histology using a directed approach; examining six cell cycle control pathway TSGs in an incident case series of 70 MPMs. Promoter hypermethylation of APC, CCND2, CDKN2A, CDKN2B, HPPBP1 and RASSF1 were assessed. We observed significantly higher lung asbestos body burden if any of these cell cycle genes were methylated (P < 0.02), and there was a significant trend of increasing asbestos body counts as the number of methylated cell cycle pathway genes increased from 0 to 1 to >1 (P < 0.005). This trend of increasing asbestos body count and increasing number of methylated cell cycle pathway genes remained significant (P < 0.05) after controlling for age, gender and tumor histology. These data suggest a novel tumorigenic mechanism of action of asbestos and may contribute to the understanding of precisely how asbestos exposure influences the etiology and clinical course of malignant mesothelioma.
Published Version: doi:10.1093/carcin/bgn059
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516493/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4874658

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters